Notably, a study has analyzed 21 ovarian cancer‐associated CTAs and found that GAGE2, CT45, CCT4, and PRAME cancer/testis antigens were revealed to be correlated with the prognosis for ovarian cancer patients.104. This evidence concerns the gene PRAME and ovarian carcinoma.